International Journal of Hospital Pharmacy

An Assessment of Knowledge and Evaluation of Risk on Developing Type II Diabetes Mellitus- a Prospective Study

Case Report of International Journal of Hospital Pharmacy An Assessment of Knowledge and Evaluation of Risk on Developing Type II Diabetes Mellitus- a Prospective Study Ms. ANCY PAUL*a, Ms. ANJU PAULa, Ms. SONA BENNYa, Mrs. DEEPTHI. C. DENNYb, Mrs. LINCY GEORGEc, Dr. K. KRISHNAKUMARd, Dr. L. Panayappane a (Pharm. D), Department of Pharmacy Practice, St. James College of Pharmaceutical Sciences, Chalakudy, b M.Pharm, Assistant Professor, Department of Pharmacy Practice, St. James College of Pharmaceutical Sciences, Chalakudy, c M.Pharm, (Ph.D), Assistant Professor, Department of Pharmacy Practice, St.James College of Pharmaceutical Sciences, Chalakudy, d M.Pharm, Ph.D, Principal, St. James College of Pharmaceutical Sciences, Chalakudy, eM.Pharm, Ph.D, Head of Department of Pharmacy Practice. Background: As per WHO definition Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. Recent study estimates that there were 171 million people in the world with diabetes in the year 2000 and this is projected to increase to 366 million by 2030. WHO projects that diabetes will be the 7th leading cause of death in 2030. Aim: To identify and improve the level of knowledge in type II Diabetes and to evaluate risk of developing type II DM among non-diabetics attending tertiary care hospital. Methods: A qualitative observational interview based method was conducted out in a 450 bedded tertiary care hospital for a period of 6 months. Patient data was collected through structured form and evaluated using standard validated scales DKQ – 24 item questionnaire form and Type II Diabetes Risk Assessment form. All patients admitted with Type II DM with/ without co-morbidities in the age range of 18-70years will be selected. The patients with increased risk of developing Type II DM will also be evaluated. The patients who are not interested ...

Case report of west syndrome: a rare severe epilepsy in infants

Case Report of International Journal of Hospital Pharmacy Case report of west syndrome: a rare severe epilepsy in infants G. Pravalika1, Sushanta Kr Das1 and Saurabh Gupta2*  1Department of Pharm. D, CMR College of Pharmacy, Kandlakoya (V)-501 401, Hyderabad, India 2Department of Pharmacology, Indore Institute of Pharmacy, Rau pithumpur road-45331, Indore, Madhya Pradesh, India West syndrome (WS) also known as infantile spasms, is severe form of epilepsy of early childhood was first describe in 1840s. WS presents with myoclonic-tonic seizures (spasms) characterized by flexor, extensor or mixed movements with distinct electroencephalogram (EEG) pattern of hypsarrthmia and psychomotor arrest. Prevalence rate is ~ 4.0 cases per 10,000 children. Peak age of beginning is between 3 and 7 months; onset after 18 months is rare. Recent guidelines from the American Academy of Neurology and the Child Neurology Society for medical treatment of WS, recommends that ACTH is probably effective and vigabatrin is possibly effective in cessation of spasms of hypsarrhythmia. Although discovered 160 years ago, still its diagnosis, assessment and management continue to create many challenges to health care professionals and affected families. In this case of a 3 yr old male child was admitted for long period of almost 2 months before being discharged. This case was confirmed early but due to its complexity it took long time to get complete resolve of situation. ACTH with Valproate was found to effective; though ACTH showed some reactions still it was considered the best available medicine for WS. In conclusion, early detection and referral to a pediatric neurologist for clinical evaluation and prompt effective treatment is strongly recommended as it may improve prognosis ...

Manuscript Title: The title should be a brief phrase.

Author Information: List full names and affiliation of all authors, including Emails and phone numbers of corresponding author.

Abstract: The abstract should be less than 500 words. Following abstract, a list of keywords and abbreviations should be added. The keywords should be no more than 10. Abbreviation are only used for non standard and long terms.

Introduction: The introduction should included a clear statement of current problems.

Materials and Methods: This section should be clearly described.

Results and discussion: Authors may put results and discussion into a single section or show them separately.

Acknowledgement: This section includes a brief acknowledgment of people, grant details, funds

References: References should be listed in a numbered citation order at the end of the manuscript. DOIs and links to referenced articles should be added if available. Abstracts and talks for conferences or papers not yet accepted should not be cited. Examples Published Papers: 

1. Hongmei YANG. A study on the Management Mode of Modern Vocational Education in China. Global journal of Economics and Business Administration, 2018, 3: 10.DOI: 10.28933/gjeba-2018-07-2301 

Tables and figures: Tables should be used at a minimum with a short descriptive title. The preferred file formats for Figures/Graphics are GIF, TIFF, JPEG or PowerPoint.

Publication fees: We do not charge any submission charges, but authors are required to pay publication fees after their manuscripts are accepted for publication. For authors who receive our invitations, please send us the invitation code to receive the special discount.

Proofreading and Publication: A proof will be sent to the corresponding author before publication. Authors should carefully read the proof to avoid any errors and return the proof to the editorial office. Editorial office will publish the article shortly.

Withdrawal Policy: When you want to withdraw an article, please contact us. We will withdraw/retract it from our system after reviewing your request.

Terms of Use/Privacy Policy/Disclaimer/Other Policies: you agree that by using or receiving our services, you have read, understood, and agreed to be bound by all of our terms of use/privacy policy/ disclaimer/ other policies.

About the journal
The journal is hosted by eSciPub LLC. Our aim is to provide a platform that encourages publication of the most recent research and reviews for authors from all countries.

About the publisher
eSciPub LLC is a publisher to support Open Access initiative located in Houston, Texas, USA. It is a member of the largest community of professional publishers in the United States: the Independent Book Publishers Association. It hosts more than 100 Open Access journals in Medicine, Business & Economics, Agriculture, Biological Sciences, Chemistry, Education, Physical Sciences, Sociology, and Engineering and Technology.

Rapid Response Team
Please feel free to contact our rapid response team if you have any questions. Our customer representative will answer your questions shortly.

International Journal of Hospital Pharmacy